SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MJ who wrote (1086)10/7/1998 2:13:00 AM
From: jake burns  Read Replies (1) of 1510
 
Sorry, MJ, no offense meant to you personally, but I have a pet peeve about investors claiming they want their company to be successful (e.g., to conquer disease for humankind). Total crap, in my not-so-humble opinion. Do you also want Hollis-Eden to be successful in their immune based therapy ("Reversionex" is their drug). It would help AIDS sufferers, but it could kill IMNR's stock. Would AGPH shareholders root for DuPont's Sustiva? If I owned AGPH, I wouldn't. I invest to make money, not solve the world's problems. IMNR will help RA sufferers, or AIDS sufferers, with or without my investment. It's not that I don't care about the world's problems; I do. But those concerns don't impact my investment decisions. I invest for only 2 reasons. The primary one is to make money; the secondary one is to undertake a challenge. That's it.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext